ALBO Market Cap History
Below is a table of the ALBO market cap history going back to 11/4/2016:

Date ALBO Market Cap
11/4/201631.22M
12/1/2016160.15M
3/1/2017162.98M
5/1/2017134.03M
8/1/2017226.50M
11/1/2017240.11M
3/1/2018404.50M
5/1/2018364.23M
8/1/2018383.64M
11/1/2018358.38M
3/1/2019372.57M
5/1/2019423.42M
8/1/2019324.62M
9/26/2019155.73M
10/30/2019244.72M
2/24/2020366.33M
4/30/2020336.44M
7/30/2020405.80M
10/29/2020624.02M
2/18/2021707.20M
4/29/2021619.03M
7/29/2021564.39M
10/28/2021560.82M
2/22/2022635.84M
5/9/2022576.72M

Also see: ALBO Shares Outstanding History
and ALBO YTD Return
ALBO Historical Market Cap:
+69.73% CAGR
ALBO Historical Market Cap: +69.73% CAGR

Mouse over chart for data details
11/4/2016 ...5/9/2022
Albireo Pharma is a commercial-stage biopharmaceutical company focused on the development and commercialization of bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. Co.'s product pipeline includes: Bylvay, which is approved in the U.S. and Europe for the treatment of pruritis in patients with progressive familial intrahepatic cholestasis; elobixibat, which is approved in Japan for the treatment of chronic constipation; A3907, its primary candidate for the treatment of adult liver diseases; and A2342, its primary preclinical candidate for the treatment of adult viral and liver diseases. We show 25 historical shares outstanding datapoints in our ALBO shares outstanding history coverage, used to compute ALBO market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ALBO market cap history over the course of time is important for investors interested in comparing ALBO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ALBO versus a peer is one thing; comparing ALBO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ALBO can fluctuate over the course of history. With this page we aim to empower investors researching ALBO by allowing them to research the ALBO market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree ALBO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Albireo Pharma (ALBO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ALC Market Cap History
ALDR Market Cap History
ALDX Market Cap History
ALEC Market Cap History
ALGN Market Cap History
ALGS Market Cap History
ALHC Market Cap History
ALIM Market Cap History
ALKS Market Cap History
ALLK Market Cap History
More Healthcare companies »

 

ALBO Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.